Inotiv, Inc. (NOTV)
USD 3.95
(-28.83%)
USD 3.95
(-28.83%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 246.9 Million USD | -2.23% |
| 2022 | 184.65 Million USD | 416.18% |
| 2021 | 35.77 Million USD | 67.95% |
| 2020 | 21.3 Million USD | 62.92% |
| 2019 | 13.07 Million USD | 61.37% |
| 2018 | 8.1 Million USD | 26.22% |
| 2017 | 6.41 Million USD | -1.15% |
| 2016 | 6.49 Million USD | -9.62% |
| 2015 | 7.18 Million USD | -0.95% |
| 2014 | 7.25 Million USD | 16.53% |
| 2013 | 6.22 Million USD | -33.27% |
| 2012 | 9.32 Million USD | 1.19% |
| 2011 | 9.21 Million USD | -1.19% |
| 2010 | 9.33 Million USD | -20.47% |
| 2009 | 11.73 Million USD | -6.44% |
| 2008 | 12.53 Million USD | 9.97% |
| 2007 | 11.4 Million USD | -33.83% |
| 2006 | 17.23 Million USD | 22.36% |
| 2005 | 14.08 Million USD | 24.86% |
| 2004 | 11.28 Million USD | 17.38% |
| 2003 | 9.61 Million USD | 7.53% |
| 2002 | 8.93 Million USD | 3.56% |
| 2001 | 8.62 Million USD | -12.24% |
| 2000 | 9.83 Million USD | 0.34% |
| 1999 | 9.8 Million USD | -1.01% |
| 1998 | 9.9 Million USD | 23.75% |
| 1997 | 8 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 52.93 Million USD | 100.69% |
| 2024 Q3 | 24.25 Million USD | -20.97% |
| 2024 Q1 | 26.37 Million USD | -36.04% |
| 2023 Q2 | 47.05 Million USD | 2.53% |
| 2023 Q3 | 46.34 Million USD | -1.52% |
| 2023 Q4 | 41.24 Million USD | -11.01% |
| 2023 Q1 | 45.89 Million USD | -5.73% |
| 2023 FY | 180.53 Million USD | -2.23% |
| 2022 Q3 | 46.14 Million USD | 25.21% |
| 2022 Q1 | 52.96 Million USD | 286.16% |
| 2022 Q2 | 36.85 Million USD | -30.41% |
| 2022 FY | 184.65 Million USD | 416.18% |
| 2022 Q4 | 48.68 Million USD | 5.5% |
| 2021 Q1 | 5.86 Million USD | -2.19% |
| 2021 Q3 | 9.34 Million USD | 37.47% |
| 2021 FY | 35.77 Million USD | 67.95% |
| 2021 Q4 | 13.71 Million USD | 46.71% |
| 2021 Q2 | 6.8 Million USD | 16.0% |
| 2020 Q1 | 4.49 Million USD | 4.41% |
| 2020 Q4 | 5.99 Million USD | 10.57% |
| 2020 Q3 | 5.42 Million USD | 0.61% |
| 2020 FY | 21.3 Million USD | 62.92% |
| 2020 Q2 | 5.38 Million USD | 19.81% |
| 2019 Q1 | 2.37 Million USD | -26.72% |
| 2019 Q4 | 4.3 Million USD | 27.46% |
| 2019 FY | 13.07 Million USD | 61.37% |
| 2019 Q3 | 3.37 Million USD | 12.26% |
| 2019 Q2 | 3.01 Million USD | 26.58% |
| 2018 Q3 | 1.65 Million USD | 1.66% |
| 2018 Q1 | 1.57 Million USD | -0.13% |
| 2018 FY | 8.1 Million USD | 26.22% |
| 2018 Q4 | 3.24 Million USD | 95.84% |
| 2018 Q2 | 1.63 Million USD | 3.82% |
| 2017 Q3 | 1.59 Million USD | 7.12% |
| 2017 Q1 | 1.76 Million USD | -5.36% |
| 2017 FY | 6.41 Million USD | -1.15% |
| 2017 Q2 | 1.48 Million USD | -15.69% |
| 2017 Q4 | 1.57 Million USD | -1.38% |
| 2016 FY | 6.49 Million USD | -9.62% |
| 2016 Q2 | 1.57 Million USD | 4.3% |
| 2016 Q1 | 1.51 Million USD | -27.54% |
| 2016 Q3 | 1.53 Million USD | -2.53% |
| 2016 Q4 | 1.86 Million USD | 21.26% |
| 2015 Q1 | 1.76 Million USD | -8.99% |
| 2015 Q2 | 1.77 Million USD | 0.68% |
| 2015 Q3 | 1.57 Million USD | -11.16% |
| 2015 Q4 | 2.08 Million USD | 32.49% |
| 2015 FY | 7.18 Million USD | -0.95% |
| 2014 FY | 7.25 Million USD | 16.53% |
| 2014 Q4 | 1.93 Million USD | 12.04% |
| 2014 Q3 | 1.72 Million USD | -9.39% |
| 2014 Q2 | 1.9 Million USD | 13.31% |
| 2014 Q1 | 1.68 Million USD | -7.07% |
| 2013 FY | 6.22 Million USD | -33.27% |
| 2013 Q4 | 1.81 Million USD | 13.61% |
| 2013 Q3 | 1.59 Million USD | 25.81% |
| 2013 Q2 | 1.26 Million USD | -18.42% |
| 2013 Q1 | 1.55 Million USD | -13.0% |
| 2012 Q1 | 2.78 Million USD | 5.86% |
| 2012 Q3 | 1.97 Million USD | -29.02% |
| 2012 FY | 9.32 Million USD | 1.19% |
| 2012 Q2 | 2.78 Million USD | 0.0% |
| 2012 Q4 | 1.78 Million USD | -9.67% |
| 2011 Q2 | 2.14 Million USD | -1.42% |
| 2011 Q4 | 2.63 Million USD | 16.17% |
| 2011 Q1 | 2.17 Million USD | 8.41% |
| 2011 FY | 9.21 Million USD | -1.19% |
| 2011 Q3 | 2.26 Million USD | 5.45% |
| 2010 Q1 | 2.44 Million USD | -12.94% |
| 2010 Q2 | 2.76 Million USD | 13.18% |
| 2010 Q3 | 2.11 Million USD | -23.58% |
| 2010 FY | 9.33 Million USD | -20.47% |
| 2010 Q4 | 2 Million USD | -4.92% |
| 2009 Q4 | 2.8 Million USD | 25.66% |
| 2009 FY | 11.73 Million USD | -6.44% |
| 2009 Q1 | 3.62 Million USD | -1.71% |
| 2009 Q2 | 3.07 Million USD | -15.16% |
| 2009 Q3 | 2.23 Million USD | -27.31% |
| 2008 Q3 | 3.13 Million USD | -5.14% |
| 2008 Q4 | 3.68 Million USD | 17.36% |
| 2008 Q1 | 3.21 Million USD | 6.59% |
| 2008 Q2 | 3.3 Million USD | 2.8% |
| 2008 FY | 12.53 Million USD | 9.97% |
| 2007 Q2 | 2.72 Million USD | 2.67% |
| 2007 Q4 | 3.02 Million USD | 0.9% |
| 2007 Q3 | 2.99 Million USD | 9.75% |
| 2007 FY | 11.4 Million USD | -33.83% |
| 2007 Q1 | 2.65 Million USD | -42.27% |
| 2006 Q1 | 4.05 Million USD | 8.79% |
| 2006 Q2 | 3.76 Million USD | -7.19% |
| 2006 Q3 | 4.8 Million USD | 27.66% |
| 2006 Q4 | 4.6 Million USD | -4.33% |
| 2006 FY | 17.23 Million USD | 22.36% |
| 2005 Q1 | 2.72 Million USD | -3.82% |
| 2005 Q2 | 3.4 Million USD | 24.98% |
| 2005 Q3 | 4.09 Million USD | 20.34% |
| 2005 Q4 | 3.73 Million USD | -8.87% |
| 2005 FY | 14.08 Million USD | 24.86% |
| 2004 Q3 | 2.98 Million USD | 8.78% |
| 2004 Q1 | 2.71 Million USD | 0.99% |
| 2004 FY | 11.28 Million USD | 17.38% |
| 2004 Q4 | 2.83 Million USD | -5.22% |
| 2004 Q2 | 2.74 Million USD | 0.96% |
| 2003 Q2 | 2.4 Million USD | 8.48% |
| 2003 Q1 | 2.21 Million USD | -2.89% |
| 2003 FY | 9.61 Million USD | 7.53% |
| 2003 Q4 | 2.69 Million USD | 17.15% |
| 2003 Q3 | 2.29 Million USD | -4.41% |
| 2002 Q3 | 2.18 Million USD | -7.14% |
| 2002 Q4 | 2.28 Million USD | 4.49% |
| 2002 FY | 8.93 Million USD | 3.56% |
| 2002 Q2 | 2.35 Million USD | 11.0% |
| 2002 Q1 | 2.11 Million USD | -4.28% |
| 2001 Q4 | 2.21 Million USD | 3.83% |
| 2001 FY | 8.62 Million USD | -12.24% |
| 2001 Q3 | 2.13 Million USD | -9.39% |
| 2001 Q2 | 2.35 Million USD | -0.76% |
| 2001 Q1 | 2.37 Million USD | -17.87% |
| 2000 Q4 | 2.88 Million USD | 12.68% |
| 2000 Q2 | 2.2 Million USD | 4.9% |
| 2000 Q1 | 2.1 Million USD | -19.23% |
| 2000 Q3 | 2.56 Million USD | 16.3% |
| 2000 FY | 9.83 Million USD | 0.34% |
| 1999 Q3 | 2.5 Million USD | 4.17% |
| 1999 Q2 | 2.4 Million USD | 0.0% |
| 1999 Q1 | 2.4 Million USD | -14.29% |
| 1999 FY | 9.8 Million USD | -1.01% |
| 1999 Q4 | 2.6 Million USD | 4.0% |
| 1998 Q4 | 2.8 Million USD | 21.74% |
| 1998 Q1 | 2.4 Million USD | 19.4% |
| 1998 Q2 | 2.4 Million USD | 0.0% |
| 1998 FY | 9.9 Million USD | 23.75% |
| 1998 Q3 | 2.3 Million USD | -4.17% |
| 1997 FY | 8 Million USD | 0.0% |
| 1997 Q4 | 2.01 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bionano Genomics, Inc. | 148.99 Million USD | -65.714% |
| Prenetics Global Limited | 60.73 Million USD | -306.514% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -1417.349% |
| CareDx, Inc | 277.76 Million USD | 11.112% |
| Exact Sciences Corporation | 2.06 Billion USD | 88.018% |
| Exagen Inc. | 52.29 Million USD | -372.153% |
| Guardant Health, Inc. | 901.62 Million USD | 72.616% |
| Biodesix, Inc. | 77.41 Million USD | -218.918% |
| BioNexus Gene Lab Corp. | 3.92 Million USD | -6193.591% |
| Precipio, Inc. | 13.63 Million USD | -1710.405% |
| iSpecimen Inc. | 16.27 Million USD | -1416.858% |
| Natera, Inc. | 938.98 Million USD | 73.705% |
| Aspira Women's Health Inc. | 24.11 Million USD | -923.899% |
| Standard BioTools Inc. | 113.48 Million USD | -117.557% |
| 23andMe Holding Co. | 420.73 Million USD | 41.316% |
| Castle Biosciences, Inc. | 242.78 Million USD | -1.697% |
| Personalis, Inc. | 128.14 Million USD | -92.676% |
| Aclaris Therapeutics, Inc. | 110.52 Million USD | -123.391% |
| Applied DNA Sciences, Inc. | 16.48 Million USD | -1397.587% |
| OpGen, Inc. | 30.65 Million USD | -705.347% |
| T2 Biosystems, Inc. | 41.49 Million USD | -495.033% |
| Myriad Genetics, Inc. | 600.1 Million USD | 58.856% |
| ICON Public Limited Company | 755.64 Million USD | 67.325% |
| NeoGenomics, Inc. | 341.25 Million USD | 27.648% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -1417.349% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 77.407% |
| RadNet, Inc. | 268.87 Million USD | 8.173% |
| MDxHealth SA | 71.25 Million USD | -246.501% |
| Psychemedics Corporation | 11.33 Million USD | -2078.428% |
| Illumina, Inc. | 3.81 Billion USD | 93.525% |
| Check-Cap Ltd. | 19.28 Million USD | -1180.152% |
| Twist Bioscience Corporation | 354.18 Million USD | 30.289% |
| DarioHealth Corp. | 62.17 Million USD | -297.123% |
| Fulgent Genetics, Inc. | 171.9 Million USD | -43.627% |
| Sera Prognostics, Inc. | 39.91 Million USD | -518.541% |
| ENDRA Life Sciences Inc. | 10.52 Million USD | -2246.823% |
| OPKO Health, Inc. | 574.68 Million USD | 57.037% |
| Medpace Holdings, Inc. | 187.68 Million USD | -31.555% |
| Neogen Corporation | 405.23 Million USD | 39.072% |
| Intelligent Bio Solutions Inc. | 11.7 Million USD | -2008.696% |
| Prenetics Global Limited | 60.73 Million USD | -306.514% |
| Mainz Biomed B.V. | 27.15 Million USD | -809.258% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -2716.97% |
| Trinity Biotech plc | 46.49 Million USD | -431.031% |
| Neuronetics, Inc. | 82.25 Million USD | -200.153% |
| Sotera Health Company | 300.46 Million USD | 17.827% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -2716.97% |